The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

Cellular immunity to influenza vaccination in RTX-treated patients was similar to DMARDs-treated patients and healthy controls, while humoral immunity was severely impaired. The preservation of cellular immunity may explain the relatively low rate of infection among B-cell depleted patients.